TEVA 1138 (Acitretin 17.5 mg)
Pill imprint TEVA 1138 has been identified as Acitretin 17.5 mg.
Acitretin is used in the treatment of psoriasis; pityriasis rubra pilaris; psoriatic arthritis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 17.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TEVA 1138
- Strength:
- 17.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antipsoriatics
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA Inc.
More about acitretin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 13 Reviews – Add your own review/rating
- Drug class: antipsoriatics
Consumer resources
Other brands: Soriatane, Soriatane CK
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
